ArticleFrontiers in oncology2022

Immune checkpoint inhibitors plus capecitabine and oxaliplatin in unresectable or advanced biliary tract cancer patients: A retrospective study.

Jie Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.